APIMEDS PHARMACEUTICALS US INC COM
APIMEDS PHARMACEUTICALS US INC COM is a security (CUSIP 03771D102) tracked across SEC portfolio filings. 6 institutional managers reported $685K on Form 13F as of 2026-03-31; 2 registered fund positions totaling $172K via N-PORT as of 2026-03-31.
Summary
- Issuer: APIMEDS PHARMACEUTICALS US INC
- Class: COM
- CUSIP: 03771D102
- Asset category: EC
- 13F holders: 6
- 13F value: $685K
- 13F period: 2026-03-31
- N-PORT fund positions: 2
- N-PORT value: $172K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| Hemenway Trust Co LLC | SALEM, NH | $490K | 274,000 |
| VANGUARD GROUP INC | Valley Forge, PA | $97K | 58,992 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $72K | 40,051 |
| TWO SIGMA SECURITIES, LLC | New York, NY | $19K | 10,550 |
| UBS Group AG | Zurich, V8 | $7K | 4,187 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
More